Biotest's total assets for Q3 2024 were €1.35B, a decrease of -2.12% from the previous quarter. GB:0N70 total liabilities were €819.20M for the fiscal quarter, a -2.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.